Laddar...
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
BACKGROUND/PURPOSE: NGX-4010 (QUTENZA(™); NeurogesX Inc, San Mateo, CA), a capsaicin 8% dermal patch, is licensed in the European Union for the treatment of peripheral neuropathic pain (PNP) in nondiabetic adults and in the United States for the treatment of neuropathic pain associated with postherp...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3255992/ https://ncbi.nlm.nih.gov/pubmed/22247621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S22954 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|